Aller R - Search Results

1

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, Miranda JL, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M. Aller R, et al. Gastroenterol Hepatol. 2018 May;41(5):328-349. doi: 10.1016/j.gastrohep.2017.12.003. Epub 2018 Apr 7. Gastroenterol Hepatol. 2018. PMID: 29631866 English, Spanish.

2

G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients.

Aller R, de Luis DA, Izaola O, González Sagrado M, Conde R, Alvarez Gago T, Pacheco D, González JM, Velasco MC. Aller R, et al. Ann Hepatol. 2010 Oct-Dec;9(4):439-44. Ann Hepatol. 2010. PMID: 21057163 Free article.

3

Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease.

Aller R, De Luis DA, Izaola O, González Sagrado M, Conde R, Pacheco D, Velasco MC, Ovalle HF. Aller R, et al. Eur Rev Med Pharmacol Sci. 2012 Mar;16(3):335-41. Eur Rev Med Pharmacol Sci. 2012. PMID: 22530350

4

Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease.

Aller R, de Luis DA, Pacheco D, Velasco MC, Conde R, Izaola O, González Sagrado M. Aller R, et al. Nutr Hosp. 2012 Sep-Oct;27(5):1637-42. doi: 10.3305/nh.2012.27.5.6011. Nutr Hosp. 2012. PMID: 23478717

5

Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.

Aller R, Izaola O, Gómez S, Tafur C, González G, Berroa E, Mora N, González JM, de Luis DA. Aller R, et al. Eur Rev Med Pharmacol Sci. 2015 Aug;19(16):3118-24. Eur Rev Med Pharmacol Sci. 2015. PMID: 26367736 Free article. Clinical Trial.

6

MEDITERRANEAN DIET IS ASSOCIATED WITH LIVER HISTOLOGY IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE.

Aller R, Izaola O, de la Fuente B, De Luis Román DA. Aller R, et al. Nutr Hosp. 2015 Dec 1;32(6):2518-24. doi: 10.3305/nh.2015.32.6.10074. Nutr Hosp. 2015. PMID: 26667698 Free article.

7

Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349].

Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, López Miranda J, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego-Durán R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M. Aller R, et al. Gastroenterol Hepatol. 2018 Aug-Sep;41(7):475-476. doi: 10.1016/j.gastrohep.2018.05.011. Gastroenterol Hepatol. 2018. PMID: 29929828 English, Spanish. No abstract available.

8

Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease.

Aller R, Laserna C, Rojo MÁ, Mora N, García Sánchez C, Pina M, Sigüenza R, Durà M, Primo D, Izaola O, de Luis D. Aller R, et al. Rev Esp Enferm Dig. 2018 Oct;110(10):634-640. doi: 10.17235/reed.2018.5602/2018. Rev Esp Enferm Dig. 2018. PMID: 30032630 Free article.

9

Cholesteryl Ester Transfer Protein Variant (RS1800777) with Liver Histology in Non-Alcoholic Fatty Liver Disease Patients.

Aller R, Izaola O, Primo D, de Luis D. Aller R, et al. Ann Nutr Metab. 2018;73(4):265-270. doi: 10.1159/000493552. Epub 2018 Oct 5. Ann Nutr Metab. 2018. PMID: 30293065

10

The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.

Ampuero J, Aller R, Gallego-Durán R, Banales JM, Crespo J, García-Monzón C, Pareja MJ, Vilar-Gómez E, Caballería J, Escudero-García D, Gomez-Camarero J, Calleja JL, Latorre M, Albillos A, Salmeron J, Aspichueta P, Lo Iacono O, Francés R, Benlloch S, Fernández-Rodríguez C, García-Samaniego J, Estévez P, Andrade RJ, Turnes J, Romero-Gómez M; HEPAmet Registry. Ampuero J, et al. Among authors: aller r. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1260-1270. doi: 10.1111/apt.15015. Epub 2018 Oct 23. Aliment Pharmacol Ther. 2018. PMID: 30353552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

474 results

Search Page